The Esterified Estrogens/Methyltestosterone Shortage: Where Things Stand in 2026

If you rely on Esterified Estrogens/Methyltestosterone to manage your menopause symptoms, you've likely dealt with the frustration of hearing "we don't have it" at the pharmacy counter. You're not imagining it — this combination hormone therapy has faced ongoing availability challenges for years.

In this 2026 update, we'll cover the current status, explain why this medication remains hard to find, break down what it costs today, and share what you can do to get the treatment you need.

Is Esterified Estrogens/Methyltestosterone Still in Shortage?

As of early 2026, Esterified Estrogens/Methyltestosterone is not officially listed on the FDA Drug Shortage Database. However, that doesn't mean it's easy to find. Many patients report difficulty locating this medication at their local pharmacies, and pharmacists often confirm that supply is inconsistent.

The reality is that Esterified Estrogens/Methyltestosterone exists in a gray area — not in a formal shortage, but not reliably available either. This is largely because:

• Only a small number of manufacturers produce the generic version
• Many brand names (Estratest, Covaryx, Essian, Menogen) have been discontinued
• The product has not gone through the modern FDA approval process, which limits new manufacturer interest
• Its classification as a Schedule III controlled substance adds production complexity

For a deeper dive into why this medication is hard to find, read our full explainer: Why is Esterified Estrogens/Methyltestosterone so hard to find?

Why Has This Medication Been Hard to Find?

The availability problems with Esterified Estrogens/Methyltestosterone aren't new — they've been building for years. Here's the timeline:

Brand Discontinuations

Over the past decade, several brand-name versions of this medication have been pulled from the market. Estratest, once the most recognized brand, was discontinued. Covaryx and other brands followed suit. Each discontinuation left fewer options for patients and pharmacies.

Limited Generic Manufacturers

Today, only a handful of generic manufacturers produce Esterified Estrogens/Methyltestosterone (commonly labeled as EEMT or EEMT HS). When any single manufacturer experiences a production delay, the impact on nationwide supply is outsized.

Regulatory Complications

The methyltestosterone component makes this a controlled substance, which means DEA production quotas, enhanced security requirements, and additional regulatory oversight. These factors slow production and make it less attractive for new manufacturers to enter the market.

What Does Esterified Estrogens/Methyltestosterone Cost in 2026?

Cost is another factor that affects access. Here's what you can expect to pay:

• Average retail price: $140 to $150 for a 30-day supply (30 tablets) without insurance
• With a GoodRx coupon: As low as $34 to $39 per month
• With SingleCare: Up to 80% off retail pricing
• With insurance: Copays typically range from $10 to $50 depending on your plan's tier placement

The generic version is significantly cheaper than the discontinued brand names ever were. For a complete breakdown of savings options, see our guide on how to save money on Esterified Estrogens/Methyltestosterone.

Are There New Options for Patients in 2026?

While no new brand-name versions of Esterified Estrogens/Methyltestosterone have been launched, patients do have more options than they may realize:

Compounding Pharmacies

Compounding pharmacies can prepare custom formulations containing both esterified estrogens and methyltestosterone (or bioidentical testosterone). This is an increasingly popular option for patients who can't find the manufactured product. Your doctor can write a compounding prescription specifying your exact dose.

Alternative Hormone Therapies

If you're open to switching, several widely available alternatives exist:

• Estradiol (patches, pills, gels) — starting around $10-$20/month with coupons
• Premarin — conjugated estrogens, around $30-$60/month
• Prempro — estrogen plus progestin combination, around $30-$50/month
• Bijuva — bioidentical estradiol and progesterone

Learn more about these options in our alternatives guide.

Telehealth Menopause Care

Menopause-focused telehealth platforms have expanded significantly, making it easier to find prescribers experienced with hormone therapy. While Esterified Estrogens/Methyltestosterone's controlled substance status may limit some telehealth prescribing, many platforms can help manage your overall menopause care.

How to Find Esterified Estrogens/Methyltestosterone in Stock Right Now

If you want to stick with this medication, here are your best strategies for finding it:

1. Use Medfinder to check real-time pharmacy availability in your area
2. Call independent pharmacies — they often have more flexibility in sourcing niche medications
3. Try mail-order pharmacy through your insurance plan for larger inventory access
4. Ask your pharmacist to special order — even if it's not on the shelf, they may be able to get it within 1-2 business days
5. Check both strengths — if the full strength is unavailable, the half strength may be in stock (or vice versa)

For detailed strategies, read our complete guide to finding Esterified Estrogens/Methyltestosterone in stock.

Final Thoughts

The Esterified Estrogens/Methyltestosterone supply situation in 2026 isn't a formal FDA shortage, but it's a real problem for the women who depend on it. Limited manufacturers, discontinued brand names, and controlled substance regulations create a perfect storm of inconsistent availability.

The most important thing is to not go without treatment. Hot flashes and other menopause symptoms significantly impact quality of life, and there are ways to get the medication you need — or an effective alternative. Start by checking Medfinder for current pharmacy availability, and work with your doctor to ensure uninterrupted care.

Stay informed — we'll continue to update this page as the availability situation evolves throughout 2026.